Authors: Fiocchi, Alessandro; Olivieri, Dario; Marcassa, Sergio; Zava, D.; Robberto, Elisa

Source: Allergy and Asthma Proceedings, Volume 30, Supplement 1, July/August 2009 , pp. S37-S39(3)

Publisher: OceanSide Publications, Inc

Abstract:

In childhood, recurrent airway infections are the most common cause for medical visits and hospitalizations. Their economic impact is considerable and their treatment accounts for a substantial quota of the health care budget. Despite documented efficacy and safety, ribosomal bacterial vaccine and membrane fraction use is still limited by being prevalently considered for prevention rather than treatment. The objective of this study was to analyze the economic benefit achieved with ribosomal immunotherapy. A review was performed of available literature data on economic parameters. Pharmacoeconomic studies published during the past few years showed how the use of ribosome component immune modulator is capable of reducing expenditure associated with treatment of recurrent respiratory infection and allows achievement of substantial savings in terms of cost, time, and loss of productivity. The initial cost of prevention in patients suffering from chronic respiratory infections is offset by a subsequent saving arising from less recurrence of disease. Direct management costs such as therapy courses, medical visits, medical exams, hospitalizations, etc., and indirect costs such as absence from school and work are not routinely considered by primary care physicians.

Keywords: Costs; economic parameters; immunomodulation treatment; otitis media; pharmacoeconomics; respiratory infections; ribosome-component immune modulator (RCIM); rhinopharyngitis; risk reduction; saving

Document Type: Research article

DOI: http://dx.doi.org/10.2500/aap.2009.30.3246

Affiliations: 1: Department of Child and Maternal Medicine, Melloni Hospital, Milan, Italy

Publication date: 2009-07-01

More about this publication?

• Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
  
  The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
  
  Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
  
  Articles marked "F" offer free full text for personal noncommercial use only.
  
  The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
• Editorial Board
• Information for Authors
• Submit a Paper
• Information for Advertisers
• Reprint Requests
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Allergy & Immunology
• By this author: Fiocchi, Alessandro ;  Olivieri, Dario ;  Marcassa, Sergio ;  Zava, D. ;  Robberto, Elisa

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers